272 related articles for article (PubMed ID: 30096051)
1. Therapeutic Drug Monitoring of Levetiracetam in Select Populations.
Jarvie D; Mahmoud SH
J Pharm Pharm Sci; 2018; 21(1s):149s-176s. PubMed ID: 30096051
[TBL] [Abstract][Full Text] [Related]
2. Review on the relevance of therapeutic drug monitoring of levetiracetam.
Sourbron J; Chan H; Wammes-van der Heijden EA; Klarenbeek P; Wijnen BFM; de Haan GJ; van der Kuy H; Evers S; Majoie M
Seizure; 2018 Nov; 62():131-135. PubMed ID: 30237016
[TBL] [Abstract][Full Text] [Related]
3. Influence of Sex, Age, and Weight on Levetiracetam Pharmacokinetics.
Alzueta N; Ortega A; Aldaz A
Ther Drug Monit; 2018 Oct; 40(5):628-634. PubMed ID: 29965883
[TBL] [Abstract][Full Text] [Related]
4. Levetiracetam Clinical Pharmacokinetic Monitoring in Pediatric Patients with Epilepsy.
Tan J; Paquette V; Levine M; Ensom MHH
Clin Pharmacokinet; 2017 Nov; 56(11):1267-1285. PubMed ID: 28353057
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic drug monitoring and the therapeutic reference range of levetiracetam for Chinese patients: Problems and issues.
Shi M; Liu C; He L; Wu H; Wu Y
Seizure; 2023 Jul; 109():26-33. PubMed ID: 37192596
[TBL] [Abstract][Full Text] [Related]
6. Levetiracetam circulating concentrations and response in status epilepticus.
Perrenoud M; André P; Buclin T; Decosterd LA; Rossetti AO; Novy J
Epilepsy Behav; 2018 Nov; 88():61-65. PubMed ID: 30241055
[TBL] [Abstract][Full Text] [Related]
7. Correlation of levetiracetam concentration in peripheral blood mononuclear cells with clinical efficacy: A sensitive monitoring biomarker in patients with epilepsy.
Harby SA; Nassra RA; Mekky JF; Ali SM; Ismail CA
Seizure; 2020 May; 78():71-77. PubMed ID: 32213443
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetic variability of newer antiepileptic drugs: when is monitoring needed?
Johannessen SI; Tomson T
Clin Pharmacokinet; 2006; 45(11):1061-75. PubMed ID: 17048972
[TBL] [Abstract][Full Text] [Related]
9. Population pharmacokinetics and dose-response relationship of levetiracetam in adult patients with epilepsy.
Rhee SJ; Shin JW; Lee S; Moon J; Kim TJ; Jung KY; Park KI; Lee ST; Jung KH; Yu KS; Jang IJ; Chu K; Lee SK
Epilepsy Res; 2017 May; 132():8-14. PubMed ID: 28279893
[TBL] [Abstract][Full Text] [Related]
10. Is Therapeutic Drug Monitoring of Lacosamide Needed in Patients with Seizures and Epilepsy?
Schultz L; Mahmoud SH
Eur J Drug Metab Pharmacokinet; 2020 Jun; 45(3):315-349. PubMed ID: 31950342
[TBL] [Abstract][Full Text] [Related]
11. Population pharmacokinetics of levetiracetam in neonates with seizures.
Lima-Rogel V; López-López EJ; Medellín-Garibay SE; Gómez-Ruiz LM; Romero-Méndez C; Milán-Segovia RC; Romano-Moreno S
J Clin Pharm Ther; 2018 Jun; 43(3):422-429. PubMed ID: 29265480
[TBL] [Abstract][Full Text] [Related]
12. Levetiracetam Pharmacokinetics in a Critically Ill Anephric Patient on Intermittent Hemodialysis.
Wieruszewski PM; Kashani KB; Rabinstein AA; Frazee E
Neurocrit Care; 2018 Apr; 28(2):243-246. PubMed ID: 28828726
[TBL] [Abstract][Full Text] [Related]
13. Levetiracetam optimal dose-finding as first-line treatment for neonatal seizures occurring in the context of hypoxic-ischaemic encephalopathy (LEVNEONAT-1): study protocol of a phase II trial.
Favrais G; Ursino M; Mouchel C; Boivin E; Jullien V; Zohar S; Saliba E
BMJ Open; 2019 Jan; 9(1):e022739. PubMed ID: 30679288
[TBL] [Abstract][Full Text] [Related]
14. The effect of serum levetiracetam concentrations on therapeutic response and IL1-beta concentration in patients with epilepsy.
Gulcebi MI; Kendirli T; Turgan ZA; Patsalos PN; Onat Yilmaz F
Epilepsy Res; 2018 Dec; 148():17-22. PubMed ID: 30326332
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetic and Pharmacodynamic Evaluation of Intravenous Levetiracetam in Children With Epilepsy.
Kim MJ; Yum MS; Yeh HR; Ko TS; Lim HS
J Clin Pharmacol; 2018 Dec; 58(12):1586-1596. PubMed ID: 30052270
[TBL] [Abstract][Full Text] [Related]
16. The treatment of neonatal seizures: focus on Levetiracetam.
Loiacono G; Masci M; Zaccara G; Verrotti A
J Matern Fetal Neonatal Med; 2016; 29(1):69-74. PubMed ID: 25385270
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic drug monitoring in pregnancy: Levetiracetam.
Fallik N; Trakhtenbroit I; Fahoum F; Goldstein L
Epilepsia; 2024 May; 65(5):1285-1293. PubMed ID: 38400747
[TBL] [Abstract][Full Text] [Related]
18. Clinical value of therapeutic drug monitoring for levetiracetam in pediatric patients with epilepsy.
Yamamoto Y; Ohta A; Usui N; Imai K; Kagawa Y; Takahashi Y
Brain Dev; 2023 May; 45(5):285-292. PubMed ID: 36759254
[TBL] [Abstract][Full Text] [Related]
19. Effect of age and comedication on levetiracetam pharmacokinetics and tolerability.
Hirsch LJ; Arif H; Buchsbaum R; Weintraub D; Lee J; Chang JT; Resor SR; Bazil CW
Epilepsia; 2007 Jul; 48(7):1351-9. PubMed ID: 17573925
[TBL] [Abstract][Full Text] [Related]
20. A Practice-Based, Clinical Pharmacokinetic Study to Inform Levetiracetam Dosing in Critically Ill Patients Undergoing Continuous Venovenous Hemofiltration (PADRE-01).
Kalaria SN; Armahizer M; McCarthy P; Badjatia N; Gobburu JV; Gopalakrishnan M
Clin Transl Sci; 2020 Sep; 13(5):950-959. PubMed ID: 32223067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
